Michael J. Overman - Researcher Profile

Publications

3 shown

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)

Jennifer B. Goldstein , Ben Tran , Joe Ensor +9 more

2014 Annals of Oncology 282 citations

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Michael J. Overman , Sara Lonardi , Ka Yeung Mark Wong +17 more

Purpose Nivolumab provides clinical benefit (objective response rate [ORR], 31%; 95% CI, 20.8 to 42.9; disease control rate, 69%; 12-month overall survival [OS], 73%) in previou...

2018 Journal of Clinical Oncology 1962 citations

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson , Alan P. Venook , Mahmoud M. Al-Hawary +36 more

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colo...

2021 Journal of the National Comprehensive... 1622 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 3,866
Institution: The University of Texas MD Anderson Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5377-135X

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.